about
description
clinical trial
@en
klinisch onderzoek
@nl
name
Osimertinib In EGFR Mutant Lung Cancer
@en
type
label
Osimertinib In EGFR Mutant Lung Cancer
@en
prefLabel
Osimertinib In EGFR Mutant Lung Cancer
@en
P1476
A Phase II Study of Osimertini ...... vanced EGFR Mutant Lung Cancer
@en
P3098
NCT03586453
P4844
P580
2018-08-13T00:00:00Z
P582
2021-03-01T00:00:00Z